| scholarly article | Q13442814 |
| P50 | author | Tapani Rönnemaa | Q16990256 |
| Olli Raitakari | Q23039996 | ||
| Marjo-Riitta Järvelin | Q28050155 | ||
| Mika Kähönen | Q29839349 | ||
| Terho Lehtimäki | Q29839397 | ||
| Samuli Ripatti | Q29839402 | ||
| Johannes Kettunen | Q30112515 | ||
| Peter Würtz | Q30158273 | ||
| Mika Ala-Korpela | Q30158291 | ||
| Ville-Petteri Mäkinen | Q42630492 | ||
| Tuija Tammelin | Q57152720 | ||
| Antti J Kangas | Q62005756 | ||
| P2093 | author name string | Pasi Soininen | |
| Markku J Savolainen | |||
| Jorma S Viikari | |||
| Taru Tukiainen | |||
| P2860 | cites work | Discovery of sexual dimorphisms in metabolic and genetic biomarkers | Q21563382 |
| Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations | Q24650362 | ||
| Genome-wide association analysis of metabolic traits in a birth cohort from a founder population | Q24654676 | ||
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| The human plasma lipidome | Q26830940 | ||
| A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance | Q28240815 | ||
| Human metabolic individuality in biomedical and pharmaceutical research | Q28247002 | ||
| Genome-wide association study identifies multiple loci influencing human serum metabolite levels | Q28258384 | ||
| New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk | Q28270700 | ||
| Mechanisms linking obesity to insulin resistance and type 2 diabetes | Q29614887 | ||
| Metabolite profiles and the risk of developing diabetes | Q29615359 | ||
| Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation | Q33991014 | ||
| Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma | Q34224637 | ||
| Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study. | Q34354390 | ||
| Disordered lipid metabolism and the pathogenesis of insulin resistance | Q34370965 | ||
| Metabolic signatures of exercise in human plasma | Q34441396 | ||
| Metabonomic, transcriptomic, and genomic variation of a population cohort | Q34476823 | ||
| Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance | Q34615295 | ||
| Mechanisms of disease:Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes | Q34737010 | ||
| Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans | Q34755232 | ||
| Role of dietary proteins and amino acids in the pathogenesis of insulin resistance | Q36897435 | ||
| Exercise training-induced improvements in insulin action. | Q37048834 | ||
| Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men | Q37120388 | ||
| Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women | Q37319222 | ||
| Metabolomics applied to diabetes research: moving from information to knowledge | Q37400761 | ||
| Consistent dietary patterns identified from childhood to adulthood: the cardiovascular risk in Young Finns Study | Q39723591 | ||
| Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance | Q40028148 | ||
| The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver | Q42096203 | ||
| Changes in insulin resistance and cardiovascular risk during adolescence: establishment of differential risk in males and females | Q42165751 | ||
| Relation of direct and surrogate measures of insulin resistance to cardiovascular risk factors in nondiabetic finnish offspring of type 2 diabetic individuals | Q42940299 | ||
| Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians | Q43850960 | ||
| Mechanism of amino acid-induced skeletal muscle insulin resistance in humans | Q43901570 | ||
| Detailed metabolic and genetic characterization reveals new associations for 30 known lipid loci | Q43983133 | ||
| Cross-sectional associations between physical activity and selected coronary heart disease risk factors in young adults. The Cardiovascular Risk in Young Finns Study | Q44604546 | ||
| High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism | Q45133042 | ||
| Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis | Q46574227 | ||
| Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. | Q46670120 | ||
| The influence of sex on the protein anabolic response to insulin | Q46777734 | ||
| Two roads diverge: weight loss interventions and circulating amino acids. | Q47379127 | ||
| A multi-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's disease | Q47401613 | ||
| The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. The Cardiovascular Risk in Young Finns Study. | Q51038040 | ||
| Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia. | Q51560606 | ||
| Role of glutamine as a glucose precursor in fasting humans. | Q51573599 | ||
| Plasma Amino Acid Levels and Insulin Secretion in Obesity | Q51685623 | ||
| Cohort Profile: The Cardiovascular Risk in Young Finns Study | Q57417503 | ||
| Stability and Robustness of Human Metabolic Phenotypes in Response to Sequential Food Challenges | Q58045554 | ||
| Effects of exogenous fatty acid concentration on glucagon-induced changes in hepatic fatty acid metabolism | Q71211265 | ||
| Change in the level of physical activity from adolescence into adulthood and obesity at the age of 31 years | Q79812118 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | insulin resistance | Q1053470 |
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 1372-1380 | |
| P577 | publication date | 2012-04-17 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | Metabolic signatures of insulin resistance in 7,098 young adults | |
| P478 | volume | 61 |
| Q91893386 | A High Level of Circulating Valine Is a Biomarker for Type 2 Diabetes and Associated with the Hypoglycemic Effect of Sitagliptin |
| Q89075954 | A collective diabetes cross in combination with a computational framework to dissect the genetics of human obesity and Type 2 diabetes |
| Q39141960 | A metabolic view on menopause and ageing |
| Q38066622 | A practical guide to metabolomic profiling as a discovery tool for human heart disease |
| Q92403812 | A randomized 3-way crossover study indicates that high-protein feeding induces de novo lipogenesis in healthy humans |
| Q33659115 | Activation of IRF1 in Human Adipocytes Leads to Phenotypes Associated with Metabolic Disease |
| Q36126574 | Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease |
| Q57464966 | Altered Dairy Protein Intake Does Not Alter Circulatory Branched Chain Amino Acids in Healthy Adults: A Randomized Controlled Trial |
| Q37659179 | Amino Acid Metabolism is Altered in Adolescents with Nonalcoholic Fatty Liver Disease-An Untargeted, High Resolution Metabolomics Study |
| Q35879306 | Association between insulin resistance and plasma amino acid profile in non-diabetic Japanese subjects |
| Q48215861 | Association between plasma concentrations of branched-chain amino acids and adipokines in Japanese adults without diabetes. |
| Q64079963 | Association of hemoglobin A1C with circulating metabolites in Dutch with European, African Surinamese and Ghanaian background |
| Q37193261 | Association of ketone body levels with hyperglycemia and type 2 diabetes in 9,398 Finnish men. |
| Q61817179 | Associations Between Dietary Protein Sources, Plasma BCAA and Short-Chain Acylcarnitine Levels in Adults |
| Q40101700 | Blood Metabolic Signatures of Body Mass Index: A Targeted Metabolomics Study in the EPIC Cohort |
| Q57171164 | Blood metabolomic measures associate with present and future glycemic control in type 2 diabetes |
| Q36593081 | Branched-chain amino acids alter neurobehavioral function in rats |
| Q28249276 | Branched-chain amino acids in metabolic signalling and insulin resistance |
| Q36629460 | Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults |
| Q64284079 | Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism |
| Q51269926 | Central adiposity-induced plasma-free amino acid alterations are associated with increased insulin resistance in healthy Singaporean adults. |
| Q46111546 | Characterization of insulin resistance in young adult survivors of childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma |
| Q47987782 | Chronic Diseases and Lifestyle Biomarkers Identification by Metabolomics. |
| Q37022557 | Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver |
| Q36109101 | Circulating metabolite predictors of glycemia in middle-aged men and women |
| Q90477603 | Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts |
| Q38544077 | Circulating microRNAs and diabetes: potential applications in medical practice. |
| Q57265122 | Comparative analysis of plasma metabolomics response to metabolic challenge tests in healthy subjects and influence of the FTO obesity risk allele |
| Q90580873 | Development of a Plasma Screening Panel for Pediatric Nonalcoholic Fatty Liver Disease Using Metabolomics |
| Q47400313 | Dietary glutamine, glutamate and mortality: two large prospective studies in US men and women |
| Q90195128 | Differences in Pregnancy Metabolic Profiles and Their Determinants between White European and South Asian Women: Findings from the Born in Bradford Cohort |
| Q36216102 | Early Antenatal Prediction of Gestational Diabetes in Obese Women: Development of Prediction Tools for Targeted Intervention |
| Q90723296 | Effect of valine on myotube insulin sensitivity and metabolism with and without insulin resistance |
| Q40616407 | Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence |
| Q37341646 | Effects of sleep restriction on the human plasma metabolome |
| Q35108988 | Effects of whole grain, fish and bilberries on serum metabolic profile and lipid transfer protein activities: a randomized trial (Sysdimet). |
| Q42769262 | Failure of homeostatic model assessment of insulin resistance to detect marked diet-induced insulin resistance in dogs |
| Q33838645 | Gene-Diet Interactions in Type 2 Diabetes: The Chicken and Egg Debate |
| Q37589850 | Genetics, genomics and metabolomics: new insights into maternal metabolism during pregnancy |
| Q37544169 | Global Metabolic Profiling of Plasma Shows that Three-Year Mild-Caloric Restriction Lessens an Age-Related Increase in Sphingomyelin and Reduces L-leucine and L-phenylalanine in Overweight and Obese Subjects |
| Q36237292 | Global deletion of BCATm increases expression of skeletal muscle genes associated with protein turnover |
| Q38225490 | High dietary protein intake, reducing or eliciting insulin resistance? |
| Q52685040 | Identification of seven novel loci associated with amino acid levels using single-variant and gene-based tests in 8545 Finnish men from the METSIM study. |
| Q37279013 | Impact of statistical models on the prediction of type 2 diabetes using non-targeted metabolomics profiling |
| Q28538482 | Improved metabolic health alters host metabolism in parallel with changes in systemic xeno-metabolites of gut origin |
| Q26745646 | Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancer |
| Q28274033 | Intervention Trials with the Mediterranean Diet in Cardiovascular Prevention: Understanding Potential Mechanisms through Metabolomic Profiling |
| Q88899703 | Jiawei Erzhiwan improves menopausal metabolic syndrome by enhancing insulin secretion in pancreatic β cells |
| Q38107445 | Measuring the exposome: a powerful basis for evaluating environmental exposures and cancer risk |
| Q90685522 | Mechanisms of Insulin Action and Insulin Resistance |
| Q30234302 | Mendelian randomization in cardiometabolic disease: challenges in evaluating causality |
| Q37036336 | Metabolic Characterization of a Rare Genetic Variation Within APOC3 and Its Lipoprotein Lipase-Independent Effects |
| Q47296686 | Metabolic Profiling of Adiponectin Levels in Adults: Mendelian Randomization Analysis |
| Q37633361 | Metabolic profiling of fatty liver in young and middle-aged adults: Cross-sectional and prospective analyses of the Young Finns Study |
| Q52606244 | Metabolic profiling of follistatin overexpression: a novel therapeutic strategy for metabolic diseases. |
| Q40098526 | Metabolic profiling of gestational diabetes in obese women during pregnancy. |
| Q40184611 | Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity |
| Q36220958 | Metabolic profiling of pregnancy: cross-sectional and longitudinal evidence |
| Q90589361 | Metabolic profiling of tissue-specific insulin resistance in human obesity: results from the Diogenes study and the Maastricht Study |
| Q42372131 | Metabolic profiling-multitude of technologies with great research potential, but (when) will translation emerge? |
| Q28542592 | Metabolic signatures of adiposity in young adults: Mendelian randomization analysis and effects of weight change |
| Q47211940 | Metabolite profiling of obese individuals before and after a one year weight loss program |
| Q47944286 | Metabolite ratios as potential biomarkers for type 2 diabetes: a DIRECT study. |
| Q37364462 | Metabolites of Glutamate Metabolism Are Associated With Incident Cardiovascular Events in the PREDIMED PREvención con DIeta MEDiterránea (PREDIMED) Trial |
| Q35919864 | Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes. |
| Q64259443 | Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome |
| Q45945181 | Metabolomic analysis of insulin resistance across different mouse strains and diets. |
| Q64240222 | Metabolomic and lipidomic assessment of the metabolic syndrome in Dutch middle-aged individuals reveals novel biological signatures separating health and disease |
| Q90854706 | Metabolomics Profile in Depression: A Pooled Analysis of 230 Metabolic Markers in 5283 Cases With Depression and 10,145 Controls |
| Q50956105 | Metabolomics allows the discrimination of the pathophysiological relevance of hyperinsulinism in obese prepubertal children. |
| Q38769689 | Metabolomics and Metabolic Diseases: Where Do We Stand? |
| Q26774386 | Metabolomics and Type 2 Diabetes: Translating Basic Research into Clinical Application |
| Q58419488 | Metabolomics for Biomarkers of Type 2 Diabetes Mellitus: Advances and Nutritional Intervention Trends |
| Q34527732 | Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis |
| Q36436985 | Metabolomics in childhood diabetes |
| Q38736350 | Metabolomics in diabetes, a review |
| Q37041169 | Metabolomics in diabetic complications |
| Q60949366 | Metabolomics of Pregnancy Complications: Emerging Application of Maternal Hair |
| Q64900569 | Metabolomics of Type 1 and Type 2 Diabetes. |
| Q37403195 | Metabolomics reveals broad-scale metabolic perturbations in hyperglycemic mothers during pregnancy |
| Q44778953 | Metabolomics reveals differences between three daidzein metabolizing phenotypes in adults with cardiometabolic risk factors |
| Q57294385 | Multi-SKAT: General framework to test for rare-variant association with multiple phenotypes |
| Q34996866 | Novel metabolic markers for the risk of diabetes development in American Indians. |
| Q92619675 | Of Older Mice and Men: Branched-Chain Amino Acids and Body Composition |
| Q30597265 | Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future |
| Q53755580 | Pharmacometabolomic signature links simvastatin therapy and insulin resistance. |
| Q51249812 | Plasma Amino Acids vs Conventional Predictors of Insulin Resistance Measured by the Hyperinsulinemic Clamp. |
| Q60919656 | Plasma Branched-Chain Amino Acids and Risk of Incident Type 2 Diabetes: Results from the PREVEND Prospective Cohort Study |
| Q35833963 | Plasma Free Amino Acid Profiles Predict Four-Year Risk of Developing Diabetes, Metabolic Syndrome, Dyslipidemia, and Hypertension in Japanese Population |
| Q37602693 | Plasma amino acid levels are elevated in young, healthy low birth weight men exposed to short-term high-fat overfeeding |
| Q47128665 | Plasma amino acid profile associated with fatty liver disease and co-occurrence of metabolic risk factors |
| Q35559687 | Plasma and urine metabolic profiles are reflective of altered beta-oxidation in non-diabetic obese subjects and patients with type 2 diabetes mellitus |
| Q45720469 | Plasma free amino acid profiles evaluate risk of metabolic syndrome, diabetes, dyslipidemia, and hypertension in a large Asian population |
| Q90288747 | Plasma metabolites associated with homeostatic model assessment of insulin resistance: metabolite-model design and external validation |
| Q38815590 | Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults. |
| Q37737774 | Plasma-free amino acid profiles are predictors of cancer and diabetes development |
| Q100736948 | Pre-diagnostic biomarkers of type 2 diabetes identified in the UAE's obese national population using targeted metabolomics |
| Q27319844 | Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses |
| Q62737150 | Proof of concept for quantitative urine NMR metabolomics pipeline for large-scale epidemiology and genetics |
| Q92095021 | Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-metabolic reprogramming |
| Q47652764 | Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies |
| Q37334527 | Race and sex differences in small-molecule metabolites and metabolic hormones in overweight and obese adults |
| Q31126519 | Random Survival Forest in practice: a method for modelling complex metabolomics data in time to event analysis |
| Q36923616 | Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity |
| Q35724602 | Relationship between insulin resistance and amino acids in women and men. |
| Q35746368 | Reliability of Serum Metabolites over a Two-Year Period: A Targeted Metabolomic Approach in Fasting and Non-Fasting Samples from EPIC. |
| Q37086913 | Serum metabolomics profiles in response to n-3 fatty acids in Chinese patients with type 2 diabetes: a double-blind randomised controlled trial |
| Q38998517 | Sex hormone-binding globulin associations with circulating lipids and metabolites and the risk for type 2 diabetes: observational and causal effect estimates |
| Q100415740 | Short-term variability of the human serum metabolome depending on nutritional and metabolic health status |
| Q64065510 | Substantial fat mass loss reduces low-grade inflammation and induces positive alteration in cardiometabolic factors in normal-weight individuals |
| Q34388081 | Systems Epidemiology: A New Direction in Nutrition and Metabolic Disease Research |
| Q52311752 | Systems biology in hepatology: approaches and applications. |
| Q27318316 | TATN-1 mutations reveal a novel role for tyrosine as a metabolic signal that influences developmental decisions and longevity in Caenorhabditis elegans |
| Q36560506 | Targeted metabolomics finds its mark in diabetes research |
| Q51595049 | The Effect of Meal Frequency on the Fatty Acid Composition of Serum Phospholipids in Patients with Type 2 Diabetes. |
| Q93126337 | The Emerging Role of l-Glutamine in Cardiovascular Health and Disease |
| Q28069578 | The Relationship between Branched-Chain Amino Acid Related Metabolomic Signature and Insulin Resistance: A Systematic Review |
| Q64058002 | The Strong Antioxidant Sheep/Goat Whey Protein Protects Against mTOR Overactivation in Rats: A Mode of Action Mimicking Fasting |
| Q91843436 | The effect of eight-week walking program on plasma levels of amino acids in early/mid pubertal obese girls |
| Q100533736 | The metabolic footprint of compromised insulin sensitivity under fasting and hyperinsulinemic-euglycemic clamp conditions in an Arab population |
| Q27027262 | The pathogenic role of persistent milk signaling in mTORC1- and milk-microRNA-driven type 2 diabetes mellitus |
| Q36530473 | Tyrosine Is Associated with Insulin Resistance in Longitudinal Metabolomic Profiling of Obese Children |
| Q41158897 | Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment. |
| Q33749444 | Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations. |
| Q36644182 | Weight loss is associated with plasma free amino acid alterations in subjects with metabolic syndrome |
| Q53406687 | Whole grains beyond fibre: what can metabolomics tell us about mechanisms? |
Search more.